JP6103700B2 - ラマン散乱を用いた心臓組織の識別方法及び装置 - Google Patents
ラマン散乱を用いた心臓組織の識別方法及び装置 Download PDFInfo
- Publication number
- JP6103700B2 JP6103700B2 JP2013103435A JP2013103435A JP6103700B2 JP 6103700 B2 JP6103700 B2 JP 6103700B2 JP 2013103435 A JP2013103435 A JP 2013103435A JP 2013103435 A JP2013103435 A JP 2013103435A JP 6103700 B2 JP6103700 B2 JP 6103700B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- raman
- raman scattering
- spectrum
- myocardial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001069 Raman spectroscopy Methods 0.000 title claims description 92
- 210000005003 heart tissue Anatomy 0.000 title claims description 45
- 238000012850 discrimination method Methods 0.000 title 1
- 210000001519 tissue Anatomy 0.000 claims description 166
- 230000002107 myocardial effect Effects 0.000 claims description 88
- 238000000034 method Methods 0.000 claims description 47
- 238000001228 spectrum Methods 0.000 claims description 45
- 230000003176 fibrotic effect Effects 0.000 claims description 43
- 230000001338 necrotic effect Effects 0.000 claims description 42
- 206010063560 Excessive granulation tissue Diseases 0.000 claims description 37
- 210000001126 granulation tissue Anatomy 0.000 claims description 37
- 238000004458 analytical method Methods 0.000 claims description 33
- 230000005284 excitation Effects 0.000 claims description 29
- 238000000491 multivariate analysis Methods 0.000 claims description 14
- 230000001678 irradiating effect Effects 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 102000018832 Cytochromes Human genes 0.000 claims description 6
- 108010052832 Cytochromes Proteins 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 230000000302 ischemic effect Effects 0.000 claims description 2
- 238000001237 Raman spectrum Methods 0.000 description 46
- 239000000523 sample Substances 0.000 description 36
- 208000010125 myocardial infarction Diseases 0.000 description 14
- 241000700159 Rattus Species 0.000 description 7
- 210000004413 cardiac myocyte Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000008520 organization Effects 0.000 description 5
- 238000012847 principal component analysis method Methods 0.000 description 4
- 206010016654 Fibrosis Diseases 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- -1 OCT compound Chemical class 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000004032 porphyrins Chemical group 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000002460 vibrational spectroscopy Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
Landscapes
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Description
図1は、本発明のラマン散乱を用いた心臓組織の識別装置の構成の一例を示す模式図である。識別装置は、心臓の組織を含む試料に励起光を照射して、試料からのラマン散乱光を検出し、検出したラマン散乱光を、少なくとも生きた心筋組織、壊死心筋組織、肉芽組織、及び線維化組織に特徴的な散乱スペクトルを指標として、多変量解析し、その解析結果に応じて心臓の組織を識別する装置である。
後述する実施例で使用した検体は、以下のように作成した。心臓全体の検体は、100%酸素供給下で全身麻酔の下、若い成体ウィスターラット(体重160−180g、雌)から取り出した。摘出された心臓は、タイロード溶液で還流、静置し、摘出後の代謝分解を最小限にした。
凍結サンプルは、20μmの厚さのセクションにクリオスタット(LEICA、Wetzler、Germany)でスライスした。ラマン分析のサンプルは、0.17mmの厚さの石英ガラス(Matsunami、大阪、日本)に載せた。ヘマトキシリンエオジン染色とアザン染色とを用いて切片の組織を確認した。
ラマンスペクトルの取得には、共焦点レーザーラマン顕微鏡(RAMAN−11:Nanophoton、大阪)を用いた。励起光には中心波長532nmのNd:YAGレーザ光を使用し、励起光強度は0.021−0.13mW/μm2 とし、露光時間は10秒として、ラマンスペクトルを測定した。正常なラットの心臓からは、生きた心筋組織に特徴的なラマンスペクトルを取得した。また、動脈結紮後の2日目、5日目、21日目のラットの心臓からは、それぞれ、壊死心筋組織、肉芽組織、線維化組織に特徴的なラマンスペクトルを取得した。この際、各ラットの心臓から9−24個のラマンスペクトルを取得した。
取得したラマンスペクトルを用いて、部分最小二乗法・判別器により、予測モデルの作成及び組織の識別を行った。部分最小二乗法・判別器は、PLS toolbox(Eigenvector Research、Wenatchee、WA)及びMATLAB(Mathworks Inc.,Natick、MA)を用いた。また、部分最小二乗法・判別器には、取得したラマンスペクトルの内、706−765cm-1及び1091−1700cm-1のラマンシフト領域を用いた。
図6は、心臓の各組織における識別結果の精度を示す図表である。図6では、本発明にて識別した生きた心筋組織、壊死心筋組織、肉芽組織、線維化組織それぞれにおける識別結果の感度(%)と特異度(%)との数値を示している。感度(%)は実際の正しい組織をどれだけ漏れなく識別できたかを表す数値であり、特異度(%)は正しくない組織をどれだけ排除できたかを表す数値である。
2 ビームスプリッタ
3 対物レンズ
4 分光器
5 検出器
6 解析部
7 識別部
8 試料台
S 試料
Claims (6)
- 心臓の組織を含む試料に励起光を照射する工程と、
前記試料からのラマン散乱光を検出する工程と、
検出されたラマン散乱光を、少なくとも生きた心筋組織、壊死心筋組織、肉芽組織、及び線維化組織それぞれに特徴的なラマン散乱スペクトルを指標として、多変量解析する解析工程と、
該解析工程にて得られた解析結果に応じて前記心臓の組織を識別する工程と
を有することを特徴とするラマン散乱を用いた心臓組織の識別方法。 - 前記解析工程にて多変量解析する際に、部分最小二乗法を用いることを特徴とする請求項1記載のラマン散乱を用いた心臓組織の識別方法。
- 前記生きた心筋組織に特徴的なラマン散乱スペクトルは、チトクロムに起因するラマン散乱スペクトルであることを特徴とする請求項1または2に記載のラマン散乱を用いた心臓組織の識別方法。
- 前記線維化組織に特徴的なラマン散乱スペクトルは、コラーゲンに起因するラマン散乱スペクトルであることを特徴とする請求項1乃至3の何れかに記載のラマン散乱を用いた心臓組織の識別方法。
- 前記試料は、虚血を起こした心臓の組織を含んでいることを特徴とする請求項1乃至4の何れかに記載のラマン散乱を用いた心臓組織の識別方法。
- 心臓の組織を含む試料に励起光を照射する手段と、
前記試料からのラマン散乱光を検出する手段と、
検出されたラマン散乱光を、少なくとも生きた心筋組織、壊死心筋組織、肉芽組織、及び線維化組織それぞれに特徴的なラマン散乱スペクトルを指標として、多変量解析する解析手段と、
該解析手段にて得られた解析結果に応じて前記心臓の組織を識別する手段と
を備えることを特徴とするラマン散乱を用いた心臓組織の識別装置。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013103435A JP6103700B2 (ja) | 2013-05-15 | 2013-05-15 | ラマン散乱を用いた心臓組織の識別方法及び装置 |
US14/278,290 US20140340675A1 (en) | 2013-05-15 | 2014-05-15 | Discrimination method and apparatus of cardiac tissue using raman scattering |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013103435A JP6103700B2 (ja) | 2013-05-15 | 2013-05-15 | ラマン散乱を用いた心臓組織の識別方法及び装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014224724A JP2014224724A (ja) | 2014-12-04 |
JP6103700B2 true JP6103700B2 (ja) | 2017-03-29 |
Family
ID=51895550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013103435A Active JP6103700B2 (ja) | 2013-05-15 | 2013-05-15 | ラマン散乱を用いた心臓組織の識別方法及び装置 |
Country Status (2)
Country | Link |
---|---|
US (1) | US20140340675A1 (ja) |
JP (1) | JP6103700B2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9425109B2 (en) * | 2014-05-30 | 2016-08-23 | Taiwan Semiconductor Manufacturing Co., Ltd. | Planarization method, method for polishing wafer, and CMP system |
JP6834560B2 (ja) * | 2017-02-13 | 2021-02-24 | 株式会社Ihi | 探索方法及び探索システム |
CN113933285A (zh) * | 2021-10-18 | 2022-01-14 | 安徽理工大学 | 一种检测肺组织胶原的非标记定量方法的建立 |
WO2023136308A1 (ja) * | 2022-01-17 | 2023-07-20 | 国立大学法人大阪大学 | ラマン散乱を用いた心筋細胞の評価方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7139598B2 (en) * | 2002-04-04 | 2006-11-21 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
EP1495309A1 (en) * | 2002-04-05 | 2005-01-12 | Massachusetts Institute Of Technology | Systems and methods for spectroscopy of biological tissue |
JP2010181391A (ja) * | 2009-02-05 | 2010-08-19 | Mutsumi Takagi | 動物細胞の識別方法 |
WO2010103661A1 (ja) * | 2009-03-13 | 2010-09-16 | 京都府公立大学法人 | ラマン散乱を用いた生体組織イメージング |
WO2010126838A1 (en) * | 2009-04-27 | 2010-11-04 | Abbott Laboratories | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
EP2270530B1 (en) * | 2009-07-01 | 2013-05-01 | Københavns Universitet | Method for prediction of lipoprotein content from NMR data |
EP2699699A4 (en) * | 2011-04-18 | 2014-12-31 | Garvan Inst Med Res | METHOD FOR THE DIAGNOSIS OF CANCER |
JP2013122437A (ja) * | 2011-11-10 | 2013-06-20 | Hoya Corp | ラマン分光測定装置、ラマン分光測定プログラム、及びそれを格納した記録媒体 |
EP2837335A4 (en) * | 2012-03-30 | 2016-01-06 | Kyoto Prefectural Public Univ Corp | METHOD FOR NERVOUS DETECTION BY SPECTROSCOPY OF RAMAN DIFFUSION |
-
2013
- 2013-05-15 JP JP2013103435A patent/JP6103700B2/ja active Active
-
2014
- 2014-05-15 US US14/278,290 patent/US20140340675A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2014224724A (ja) | 2014-12-04 |
US20140340675A1 (en) | 2014-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meyer et al. | Nonlinear microscopy, infrared, and Raman microspectroscopy for brain tumor analysis | |
Motz et al. | Real-time Raman system for in vivo disease diagnosis | |
De Jong et al. | Discrimination between nontumor bladder tissue and tumor by Raman spectroscopy | |
KR101947859B1 (ko) | 광섬유 라만 분광법을 이용하는 내시경검사로 실시간 암 진단과 관련된 방법 | |
JP7257009B2 (ja) | がん検出を目的としたリアルタイムラマン分光法のためのシステムおよび方法 | |
Ali et al. | Automatic label‐free detection of breast cancer using nonlinear multimodal imaging and the convolutional neural network ResNet50 | |
Fallahzadeh et al. | Raman spectral feature selection using ant colony optimization for breast cancer diagnosis | |
KR20170039168A (ko) | 비정상적 성장하는 표본 또는 조직의 유형 또는 특성을 분석하는 라만 분광 시스템, 장치 및 방법 | |
Baugh et al. | Non-destructive two-photon excited fluorescence imaging identifies early nodules in calcific aortic-valve disease | |
JP6103700B2 (ja) | ラマン散乱を用いた心臓組織の識別方法及び装置 | |
Tiwari et al. | Computational chemical imaging for cardiovascular pathology: chemical microscopic imaging accurately determines cardiac transplant rejection | |
Happillon et al. | Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classification | |
US20120316446A1 (en) | Raman spectral analysis for disease detection and monitoring | |
Barroso et al. | Characterization and subtraction of luminescence background signals in high‐wavenumber Raman spectra of human tissue | |
Taieb et al. | Classification of tissue biopsies by raman spectroscopy guided by quantitative phase imaging and its application to bladder cancer | |
Cluff et al. | Surface‐enhanced Raman spectral biomarkers correlate with ankle brachial index and characterize leg muscle biochemical composition of patients with peripheral arterial disease | |
Gros et al. | Characterization of polarimetric properties in various brain tumor types using wide-field imaging Mueller polarimetry | |
US10706536B2 (en) | Photon structure and chemometrics pathologic system | |
Sablinskas et al. | Fiber attenuated total reflection infrared spectroscopy of kidney tissue during live surgery | |
Buttner et al. | Label-free Imaging of Myocardial Remodeling in Atrial Fibrillation Using Nonlinear Optical Microscopy: A Feasibility Study. | |
Kreiss et al. | Label‐free analysis of inflammatory tissue remodeling in murine lung tissue based on multiphoton microscopy, Raman spectroscopy and machine learning | |
US10048210B2 (en) | Spectroscopic analysis method | |
Tsai et al. | Label-free identification and characterization of murine hair follicle stem cells located in thin tissue sections with Raman micro-spectroscopy | |
US20220386939A1 (en) | Label-free spectral pathology for in vivo diagnosis | |
WO2022041331A1 (en) | Forensic detector and the system thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160420 |
|
AA91 | Notification that invitation to amend document was cancelled |
Free format text: JAPANESE INTERMEDIATE CODE: A971091 Effective date: 20160614 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170127 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170207 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170224 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6103700 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |